CS
Credit Suisse Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1276
KB Home
KBH
$4.62B
|
AB
Adam Baumgarten
| $67.82 | $54 |
20%
downside
| Outperform |
11 Feb ‘21
4 years ago |
|
1277
Dayforce
DAY
$10.9B
|
YC
Yaoxian Chew
| $69.20 | $95 |
37%
upside
| Neutral |
10 Feb ‘21
4 years ago |
|
1278
Masco
MAS
$15.8B
|
AB
Adam Baumgarten
| $75.36 | $75 |
0%
downside
| Outperform |
10 Feb ‘21
4 years ago |
|
1279
Akamai
AKAM
$11.3B
|
BZ
Brad Zelnick
| $78.97 | $115 |
46%
upside
| Neutral |
10 Feb ‘21
4 years ago |
|
1280
Wynn Resorts
WYNN
$12.9B
|
BC
Ben Combes
| $124.46 | $99 |
20%
downside
| Neutral |
8 Feb ‘21
4 years ago |
|
1281
Corpay
CPAY
$22B
|
TC
Timothy Chiodo
| $311.01 | $270 |
13%
downside
| Neutral |
5 Feb ‘21
4 years ago |
|
1282
Ashland
ASH
$2.47B
|
CP
Chris Parkinson
| $54.10 | $103 |
90%
upside
| Outperform |
5 Feb ‘21
4 years ago |
|
|
AAMI
1283
Acadian Asset Management Inc.
AAMI
$1.61B
|
CS
Craig Siegenthaler
| $45.08 | $27 |
40%
downside
| Outperform |
5 Feb ‘21
4 years ago |
|
1284
Air Products & Chemicals
APD
$64B
|
CP
Chris Parkinson
| $287.54 | $302 |
5%
upside
| Outperform |
5 Feb ‘21
4 years ago |
|
1285
Gilead Sciences
GILD
$144B
|
ES
Evan Seigerman
| $115.91 | $66 |
43%
downside
| Neutral |
5 Feb ‘21
4 years ago |
|
1286
Corteva
CTVA
$48.9B
|
CP
Chris Parkinson
| $72 | $42 |
42%
downside
| Neutral |
5 Feb ‘21
4 years ago |
|
1287
Gen Digital
GEN
$18.3B
|
BZ
Brad Zelnick
| $29.77 | $24 |
19%
downside
| Neutral |
5 Feb ‘21
4 years ago |
|
1288
Baxter International
BAX
$12.3B
|
MM
Matt Miksic
| $24 | $95 |
296%
upside
| Outperform |
5 Feb ‘21
4 years ago |
|
1289
Biogen
BIIB
$20.8B
|
ES
Evan Seigerman
| $141.91 | $338 |
138%
upside
| Outperform |
4 Feb ‘21
4 years ago |
|
1290
Howmet Aerospace
HWM
$72.3B
|
RS
Robert Spingarn
| $179.42 | $32 |
82%
downside
| Outperform |
4 Feb ‘21
4 years ago |
|
1291
Align Technology
ALGN
$9.94B
|
EW
Erin Wright
| $137.18 | $630 |
359%
upside
| Outperform |
4 Feb ‘21
4 years ago |
|
1292
Fortune Brands Innovations
FBIN
$7.27B
|
AB
Adam Baumgarten
| $60.55 | $96 |
59%
upside
| Neutral |
3 Feb ‘21
4 years ago |
|
1293
Amgen
AMGN
$151B
|
ES
Evan Seigerman
| $279.61 | $265 |
5%
downside
| Outperform |
3 Feb ‘21
4 years ago |
|
1294
Vertex Pharmaceuticals
VRTX
$101B
|
ES
Evan Seigerman
| $393.94 | $280 |
29%
downside
| Outperform |
2 Feb ‘21
4 years ago |
|
1295
Palo Alto Networks
PANW
$132B
|
BZ
Brad Zelnick
| $196.95 | $70.83 |
64%
downside
| Outperform |
2 Feb ‘21
4 years ago |
|
1296
WisdomTree
WT
$2B
|
CS
Craig Siegenthaler
| $13.57 | $7.40 |
45%
downside
| Outperform |
1 Feb ‘21
4 years ago |
|
1297
Angi Inc
ANGI
$824M
|
YY
Yoni Yadgaran
| $18.59 | $180 |
868%
upside
| Outperform |
1 Feb ‘21
4 years ago |
|
1298
Northrop Grumman
NOC
$82.6B
|
RS
Robert Spingarn
| $577.20 | $353 |
39%
downside
| Outperform |
29 Jan ‘21
4 years ago |
|
1299
Dow Inc
DOW
$16.8B
|
CP
Chris Parkinson
| $23.67 | $50 |
111%
upside
| Neutral |
29 Jan ‘21
4 years ago |
|
1300
CACI
CACI
$10.4B
|
RS
Robert Spingarn
| $471.93 | $288 |
39%
downside
| Outperform |
29 Jan ‘21
4 years ago |
|